To characterize stromal cell heterogeneity in LUAD progression, we performed simultaneous immunofluorescence staining for ECs (CD31), fibroblasts (fibronectin) and immune cells (CD45) in normal and tumor tissues from patients of different stages (Fig. 4k and Fig. S17). The gene discussed is PTPRC; the disease is neoplasm.